KH
Kitty Hawk Capital
Venture CapitalModerateKitty Hawk Capital has provided venture capital financing to more than 70 private companies since 1980.
7
Investments
2
Exits
—
AUM
28.6%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Kitty Hawk Capital.
Investment Thesis & Strategy
Kitty Hawk Capital invests in various stages of fintech and venture capital companies, with a focus on backing established private companies.
Investment Activity
Deals per year over the last 18 years
2
20001
20010
20020
20030
20040
20052
20062
20071
20081
20090
20100
20110
20120
20130
20140
20150
20161
2017Portfolio Companies
Selected investments from their portfolio of 7 companies
D
Dendreon
Biotech · Series A, 0
B
BioTime
Biotech · Series A, 0
V
Vascular Pathways
Healthcare · Series A, 2017
E
Eos Energy Storage
Cleantech · Series A, 2009
C
Celladon
Biotech · Series A, 2008
C
CellDex Therapeutics
Biotech · Series A, 2007
C
Calera
Cleantech · Series A, 2007
K
KaloBios Pharmaceuticals
Biotech · Series A, 2006
A
Accuri Cytometers
Biotech · Series A, 2006
G
Genomic Health
Healthcare · Series A, 2001
C
Cobra Solutions
Enterprise · Series A, 2000
A
Atheromed
Healthcare · Series A, 2000
Frequently Asked Questions
Kitty Hawk Capital focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Frontier Growth
Charlotte, United States · 44 deals
Wakefield Group
Charlotte, United States · 33 deals
Capitala Group
Charlotte, United States · 11 deals
Sterling Capital Management
Charlotte, United States · 8 deals
Task Force X Capital
Charlotte, United States · 7 deals
Charlotte Angel Partners
Charlotte, United States · 4 deals